ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,634.80
      0.80%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.91
      0.54%
      Bitcoin
      60,250.43
      -2.86%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cynosure - Class A (MM) (CYNO)

      7. Cynosure - Class A (MM) (CYNO) News

      CYNO

      Cynosure (CYNO)

      Cynosure - Class A (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CYNO
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      02/11/201511:48AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CYNOCynosure - Class A (MM)
      02/10/20158:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNOCynosure - Class A (MM)
      02/10/20158:00AMPR Newswire (US)Cynosure Reports Record Quarterly Revenue of $86.3 Million for the Fourth Quarter of 2014NASDAQ:CYNOCynosure - Class A (MM)
      02/09/20158:30AMPR Newswire (US)Cynosure to Participate in Leerink Global Healthcare ConferenceNASDAQ:CYNOCynosure - Class A (MM)
      01/26/20159:40AMPR Newswire (US)Cynosure To Host Fourth-Quarter 2014 Financial Results Conference Call On February 10NASDAQ:CYNOCynosure - Class A (MM)
      01/15/20152:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNOCynosure - Class A (MM)
      01/13/201511:43AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      01/13/20157:30AMPR Newswire (US)Cynosure Appoints William O. Flannery as Lead DirectorNASDAQ:CYNOCynosure - Class A (MM)
      12/29/20148:30AMPR Newswire (US)Cynosure to Present at 17th Annual Needham Growth ConferenceNASDAQ:CYNOCynosure - Class A (MM)
      12/03/201412:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      12/03/20148:37AMPR Newswire (US)Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser TreatmentNASDAQ:CYNOCynosure - Class A (MM)
      12/03/20148:30AMPR Newswire (US)Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser TreatmentNASDAQ:CYNOCynosure - Class A (MM)
      11/25/201412:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20149:43AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20149:43AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20149:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20149:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20149:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/18/20148:00AMPR Newswire (US)Cynosure Signs Exclusive Agreement to Market MonaLisa Touch™ in North America for Gynecology IndicationsNASDAQ:CYNOCynosure - Class A (MM)
      11/17/20145:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/17/20145:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/17/20145:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYNOCynosure - Class A (MM)
      11/07/20145:22PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CYNOCynosure - Class A (MM)
      10/28/20148:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNOCynosure - Class A (MM)
      10/28/20148:00AMPR Newswire (US)Cynosure Reports Record Third-Quarter Revenue of $71.5 Million, Up 18% Year-Over-YearNASDAQ:CYNOCynosure - Class A (MM)
      10/15/20148:30AMPR Newswire (US)Cynosure To Host Third-Quarter 2014 Financial Results Conference Call On October 28NASDAQ:CYNOCynosure - Class A (MM)
      10/06/20144:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNOCynosure - Class A (MM)
      09/24/20148:30AMPR Newswire (US)Cynosure Receives Expanded FDA Clearance to Market PicoSure® for Treatment of WrinklesNASDAQ:CYNOCynosure - Class A (MM)
      09/10/20148:00AMPR Newswire (US)Cynosure Promotes Chris Aronson to Vice President of North American SalesNASDAQ:CYNOCynosure - Class A (MM)
       Showing the most relevant articles for your search:NASDAQ:CYNO